Data availability
Available upon request.
References
Bamgboye AO, Oni IO, Collier A (2020) Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review. Eur J Clin Pharmacol. https://doi.org/10.1007/s00228-020-03051-3
Clark A, Mohammed AS, Raut A, Moore S, Houlden R, Awad S (2020) Prevalence and clinical characteristics of adults presenting with sodium-glucose cotransporter-2 inhibitor-associated diabetic ketoacidosis at a Canadian Academic Tertiary Care Hospital. Can J Diabetes. https://doi.org/10.1016/j.jcjd.2020.08.100
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283(15):2008–2012. https://doi.org/10.1001/jama.283.15.2008
Lo CK, Mertz D, Loeb M (2014) Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol 14:45. https://doi.org/10.1186/1471-2288-14-45
Funding
Funding for publications costs is covered by Hamad Medical Corporation.
Author information
Authors and Affiliations
Contributions
Fateen Ata: Principal investigator, conceptualization, literature review, data gathering, manuscript writing. Zohaib Yousaf: Literature review, data gathering, statistical analysis, manuscript writing. Adeel Ahmad Khan: Literature review, data gathering, manuscript writing. Almurtada Razok: Literature review, data gathering. Jaweria Akram: Literature review, data gathering. Elrazi Awadelkarim Hamid Ali: Literature review, data gathering. Ahmed Abdalhadi: Literature review, data gathering. Mohammed I Danjuma: Literature review and manuscript writing. Dabia Hamad S H Al Mohanadi: Literature review, manuscript writing and supervision. All authors have reviewed and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was approved by MRC Qatar (MRC-01-20-064). Consent was not required as this was a retrospective data review of medical records.
Consent for publication
Consent was not required as this was a retrospective data review of medical records.
Conflict of interest
The authors declare no competing interests.
Additional information
This work has not been submitted and is not under consideration in any other journal.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yousaf, Z., Ata, F., Khan, A.A. et al. SGLT2 inhibitors and euglycemic diabetic ketoacidosis. Eur J Clin Pharmacol 77, 1431–1433 (2021). https://doi.org/10.1007/s00228-021-03120-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-021-03120-1